The Indian patent authority is issuing a precedent decision against Bayer, the pharmaceutical company, granting a manufacturer of generic drugs a compulsory license for patented medication. Dr. Jens Hammer suggests that the pharmaceutical industry, which bases its products on research, will view the judgment as dispossession. According to the patent attorney, the pharmaceutical industry might face further compulsory licensing procedures going forward.